These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 1645578

  • 1. Monoclonal antibodies recognising the cluster 2 antigen associated with human small cell lung cancer mediate the toxic effects of ricin A chain in an indirect assay of immunotoxin cytotoxicity.
    Derbyshire EJ, Wawrzynczak EJ.
    Br J Cancer Suppl; 1991 Jun; 14():74-7. PubMed ID: 1645578
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
    Wawrzynczak EJ, Derbyshire EJ, Henry RV, Parnell GD, Smith A, Waibel R, Stahel RA.
    Br J Cancer Suppl; 1991 Jun; 14():71-3. PubMed ID: 1645577
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.
    Wawrzynczak EJ, Derbyshire EJ, Henry RV, Parnell GD, Smith A, Waibel R, Stahel RA.
    Br J Cancer; 1990 Sep; 62(3):410-4. PubMed ID: 2169852
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
    Ghetie MA, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G.
    Cancer Res; 1988 May 01; 48(9):2610-7. PubMed ID: 2451562
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancer.
    Derbyshire EJ, Stahel RA, Wawrzynczak EJ.
    Cancer Immunol Immunother; 1992 May 01; 35(6):417-20. PubMed ID: 1327529
    [Abstract] [Full Text] [Related]

  • 8. Rapid screening with indirect immunotoxin for monoclonal antibodies against human small cell lung cancer.
    Weltman JK, Pedroso P, Johnson SA, Davignon D, Fast LD, Leone LA.
    Cancer Res; 1987 Nov 01; 47(21):5552-6. PubMed ID: 2822229
    [Abstract] [Full Text] [Related]

  • 9. An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancer.
    Derbyshire EJ, Wawrzynczak EJ.
    Int J Cancer; 1992 Oct 21; 52(4):624-30. PubMed ID: 1328073
    [Abstract] [Full Text] [Related]

  • 10. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW, Lee J, Stone MJ.
    Cancer Res; 1984 Nov 21; 44(11):4987-92. PubMed ID: 6207911
    [Abstract] [Full Text] [Related]

  • 11. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
    Wiels J, Junqua S, Dujardin P, Le Pecq JB, Tursz T.
    Cancer Res; 1984 Jan 21; 44(1):129-33. PubMed ID: 6690030
    [Abstract] [Full Text] [Related]

  • 12. Antigens associated with multidrug resistance in H69AR, a small cell lung cancer cell line.
    Mirski SE, Cole SP.
    Cancer Res; 1989 Oct 15; 49(20):5719-24. PubMed ID: 2571409
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V, Ritz J, Basala M, Schlossman SF.
    Cancer Res; 1982 Feb 15; 42(2):457-64. PubMed ID: 6948605
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
    Engert A, Martin G, Pfreundschuh M, Amlot P, Hsu SM, Diehl V, Thorpe P.
    Cancer Res; 1990 May 15; 50(10):2929-35. PubMed ID: 1692251
    [Abstract] [Full Text] [Related]

  • 15. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
    Fogler WE, Klinger MR, Abraham KG, Gottlinger HG, Riethmuller G, Daddona PE.
    Cancer Res; 1988 Nov 15; 48(22):6303-8. PubMed ID: 2460221
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
    Griffin TW, Pagnini PG, Houston LL.
    J Biol Response Mod; 1987 Oct 15; 6(5):537-45. PubMed ID: 3500277
    [Abstract] [Full Text] [Related]

  • 17. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
    Shen GL, Li JL, Vitetta ES.
    J Immunol; 1994 Mar 01; 152(5):2368-76. PubMed ID: 8133047
    [Abstract] [Full Text] [Related]

  • 18. [Preparation of an anti-human immunotoxin against bladder carcinoma and its in vitro targeting cytotoxicity].
    Zhao C.
    Zhonghua Zhong Liu Za Zhi; 1992 Mar 01; 14(2):109-11. PubMed ID: 1618077
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.